Replies to post #249896 on Innovation Pharmaceuticals Inc (IPIX)

[MXAMDUD]

delay, distort and deceive.

Words Leo lives by

[loanranger]

"However, common sense as one poster suggested back in September, there will not be a deal until the EOP 2 Meeting is over."

Yet just today we were provided with an example of one drug developer that dangled a seat at their upcoming EOP2 meeting as leverage to get a deal signed BEFORE the meeting, creating some heightened competition among 3 interested parties and succeeded at finalizing their deal.

I guess common sense didn't apply in that case :o)

But if in the IPIX case there is only one interested party they may very well wait. The minutes of the meeting will be made available by the FDA within 30 days of the meeting and the Company will be free to share them with any interested parties at that point.

[To infinity and beyond!]

Topline data were December, and that is when any real interest would have started . The clock has been running almost ONE YEAR- NOT starting in May

The May data are critical in the time line of misleading and bogus data from IPIX. As with the pathetic and misleading reporting of P2a, so the laughable small subsets of data re B OM. Insulting bogus data that had no business getting a PR.

Agree that the ease of use the swish and spit for a drug that did well statistically for one subgroup is promising- BUT it was not promising enough to get a BTD. One wonders why, then, those that have looked very carefully at the data- The FDA, that is- saw fit not to grant BTD. Why? If the data are so great then why no deal from pharma, either, after one whole year? Why?